Health
Abbott’s Once-A-Day Ivabradine Receives DCGI Approval for Heart Failure and Angina patients
• Approval marks the first once-a-day formulation for Ivabradine in India, which will help increase adherence to therapy for chronic heart failure and chronic stable angina • It is estimated that 1.3 to 4.6 million […]